BiotechTube
Home/GEn1E Lifesciences/François Nader, MD
FN

François Nader, MD

Chairman of the Board

GEn1E Lifesciences

Therapeutic Areas

Inflammatory DiseasesRare DiseasesRespiratoryImmuno-oncology

GEn1E Lifesciences Pipeline

DrugIndicationPhase
GEn-1124Acute Respiratory Distress Syndrome (ARDS)Phase 2
Chronic Oral p38α:MK2 Dual Signal ModulatorsUndisclosed (Stealth)Discovery/Preclinical
Chronic Oral NextGen ERK 1/2 ModulatorsUndisclosed (Stealth) in Immuno-oncologyDiscovery/Preclinical